S100 positivity was reported in primary cutaneous melanomas [18,19,20], Spitzoid melanomas [21], amelanotic melanomas [22,23], nodular melanomas [24], and desmoplastic/spindle cell melanomas [25,26,27,28,29]. This evidence concerns the gene S100B and nodular malignant melanoma.